The Permanent Representatives Committee (Coreper) of the EU Council is scheduled to meet on 22 July 2026 in Brussels to seek agreement on two key legislative files: the revision of the Carcinogens, Mutagens and Reprotoxic Substances Directive (sixth batch) and the Regulation on the European Chemicals Agency (ECHA). The provisional agenda, published on 17 July 2026, lists these as discussion items requiring analysis of final compromise texts with a view to agreement.
The meeting, which begins at 09:00, will also include an information point from the Commission on the Emissions Trading System Review Package and the Electrification Action Plan under any other business. Coreper will adopt by silence or approval a series of non-discussion items, including replies to written questions from MEPs, attendance of third parties at working parties, an appeal case on protected geographical indications, authorisation to negotiate a non-binding instrument on energy connectivity, a mandate for negotiations with the European Parliament on joint RFMO transpositions, and decisions on written procedures for the European Disability Card and UNCCD COP17.
No prior coverage of these specific files exists in recent records, making this meeting a fresh step in the legislative process. The revision of Directive 2004/37/EC aims to further protect workers from carcinogens and reprotoxic substances, impacting employers and employees across EU member states. The ECHA regulation update seeks to enhance the agency's role in chemical safety, affecting chemical manufacturers, importers, and downstream users. Both files have been subject to lengthy negotiations, and Coreper's agreement would pave the way for formal adoption by the Council.
Workers in industries handling hazardous substances stand to benefit from stricter exposure limits, while businesses may face higher compliance costs. ECHA's strengthened mandate could increase regulatory burdens for chemical companies but improve safety standards. EU member states will need to transpose the directive into national law, potentially requiring adjustments to existing occupational health frameworks. The European Parliament will need to approve the final texts if Coreper reaches agreement, with trilogue negotiations likely to follow.